Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-29 Exercise | 2024-03-05 6:10 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 2,537 | $1.2 | 1,551,261 (Direct) | View |
| 2024-02-29 Exercise | 2024-03-05 6:10 pm | N/A 2033-02-03 | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 21,448 | $0 | 1,551,261 (Direct) | View |
| 2024-02-29 Exercise | 2024-03-05 6:10 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 18,911 | $1.69 | 1,551,261 (Direct) | View |
| 2023-11-20 Exercise | 2023-12-14 4:00 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 2,536 | $1.2 | 1,324,309 (Direct) | View |
| 2023-12-11 Exercise | 2023-12-14 4:00 pm | N/A 2033-02-03 | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 8,840 | $0 | 1,324,309 (Direct) | View |
| 2023-11-20 Exercise | 2023-12-14 4:00 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 6,304 | $1.69 | 1,324,309 (Direct) | View |
| 2023-11-20 Exercise | 2023-11-22 1:48 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 27,900 | $1.2 | 1,324,309 (Direct) | View |
| 2023-11-20 Exercise | 2023-11-22 1:48 pm | N/A 2033-02-03 | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 84,637 | $0 | 1,324,309 (Direct) | View |
| 2023-11-20 Exercise | 2023-11-22 1:48 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 56,737 | $1.69 | 1,324,309 (Direct) | View |
| 2023-02-03 Option Award | 2023-02-07 4:08 pm | N/A 2033-02-03 | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 302,600 | $0 | 1,286,336 (Direct) | View |
| 2023-01-13 Option Award | 2023-02-07 4:08 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 5,000 | $1.49 | 1,286,336 (Direct) | View |
| 2022-12-21 Exercise | 2022-12-23 4:47 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 30,437 | $1.2 | 1,011,709 (Direct) | View |
| 2022-12-21 Exercise | 2022-12-23 4:47 pm | N/A 2028-12-10 | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 136,782 | $0 | 1,011,709 (Direct) | View |
| 2022-12-21 Exercise | 2022-12-23 4:47 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 106,345 | $1.03 | 1,011,709 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 5:02 pm | N/A 2032-02-22 | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 106,200 | $0 | 106,200 (Direct) | View |
Ownership | 2021-06-17 9:13 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD See Remarks | 0 | $0 | 1,512,048 (Direct) | View |